Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2005-06-02
2010-10-19
Helms, Larry R. (Department: 1643)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C530S387100, C530S388100
Reexamination Certificate
active
07815907
ABSTRACT:
The present invention relates to antibodies and antigen-binding portions thereof that specifically bind to insulin-like growth factor I receptor (IGF-IR), which is preferably human IGF-IR. The invention also relates to human anti-IGF-IR antibodies, including chimeric, bispecific, derivatized, single chain antibodies or portions of fusion proteins. The invention also relates to isolated heavy and light chain immunoglobulin molecules derived from anti-IGF-IR antibodies and nucleic acid molecules encoding such molecules. The present invention also relates to methods of making anti-IGF-IR antibodies, pharmaceutical compositions comprising these antibodies and methods of using the antibodies and compositions thereof for diagnosis and treatment. The invention also provides gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-IGF-IR antibodies. The invention also relates to gene therapy methods and transgenic animals comprising nucleic acid molecules of the present invention.
REFERENCES:
patent: 4399216 (1983-08-01), Axel et al.
patent: 4510245 (1985-04-01), Cousens et al.
patent: 4634665 (1987-01-01), Axel et al.
patent: 4740461 (1988-04-01), Kaufman
patent: 4912040 (1990-03-01), Kaufman et al.
patent: 4959455 (1990-09-01), Clark et al.
patent: 4968615 (1990-11-01), Koszinowski et al.
patent: 5151510 (1992-09-01), Stec et al.
patent: 5168062 (1992-12-01), Stinski
patent: 5179017 (1993-01-01), Axel et al.
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5530101 (1996-06-01), Queen et al.
patent: 5545806 (1996-08-01), Lonberg et al.
patent: 5545807 (1996-08-01), Surani et al.
patent: 5585089 (1996-12-01), Queen et al.
patent: 5587458 (1996-12-01), King et al.
patent: 5591669 (1997-01-01), Krimpenfort et al.
patent: 5612205 (1997-03-01), Kay et al.
patent: 5625126 (1997-04-01), Lonberg et al.
patent: 5625825 (1997-04-01), Rostoker et al.
patent: 5633425 (1997-05-01), Lonberg et al.
patent: 5643763 (1997-07-01), Dunn et al.
patent: 5661016 (1997-08-01), Lonberg et al.
patent: 5693761 (1997-12-01), Queen et al.
patent: 5693792 (1997-12-01), Torii et al.
patent: 5714350 (1998-02-01), Co et al.
patent: 5721367 (1998-02-01), Kay et al.
patent: 5741957 (1998-04-01), Deboer et al.
patent: 5747498 (1998-05-01), Schnur et al.
patent: 5750172 (1998-05-01), Meade et al.
patent: 5756687 (1998-05-01), Denman et al.
patent: 5770429 (1998-06-01), Lonberg et al.
patent: 5777085 (1998-07-01), Co et al.
patent: 5789215 (1998-08-01), Berns et al.
patent: 5789650 (1998-08-01), Lonberg et al.
patent: 5792783 (1998-08-01), Tang et al.
patent: 5814318 (1998-09-01), Lonberg et al.
patent: 5827690 (1998-10-01), Meade et al.
patent: 5834504 (1998-11-01), Tang et al.
patent: 5861510 (1999-01-01), Piscopio et al.
patent: 5863949 (1999-01-01), Robinson et al.
patent: 5869045 (1999-02-01), Hellstrom et al.
patent: 5877305 (1999-03-01), Huston et al.
patent: 5883113 (1999-03-01), Tang et al.
patent: 5886020 (1999-03-01), Tang et al.
patent: 5886152 (1999-03-01), Nakatani et al.
patent: 5916771 (1999-06-01), Hori et al.
patent: 5939598 (1999-08-01), Kucherlapati et al.
patent: 5985615 (1999-11-01), Jakobovits et al.
patent: 5994619 (1999-11-01), Stice et al.
patent: 5998209 (1999-12-01), Jokobovits et al.
patent: 6054297 (2000-04-01), Carter et al.
patent: 6075181 (2000-06-01), Kucherlapati et al.
patent: 6084085 (2000-07-01), Baserga et al.
patent: 6091001 (2000-07-01), Jakobovits et al.
patent: 6114598 (2000-09-01), Kucherlapati et al.
patent: 6130364 (2000-10-01), Jakobovits et al.
patent: 6146629 (2000-11-01), Dagan et al.
patent: 6657103 (2003-12-01), Kucherlapati et al.
patent: 7371378 (2008-05-01), Cohen et al.
patent: 2003/0165502 (2003-09-01), Fujita-Yamaguchi
patent: 2003/0235582 (2003-12-01), Singh et al.
patent: 2005/0048050 (2005-03-01), Fujita-Yamaguchi
patent: 2008/0124339 (2008-05-01), Pullen et al.
patent: 0 216 846 (1987-04-01), None
patent: 0 256 055 (1988-02-01), None
patent: 0 323 997 (1989-07-01), None
patent: 0 338 841 (1989-10-01), None
patent: 0 606 046 (1994-07-01), None
patent: 0 780 386 (1997-06-01), None
patent: 0 818 442 (1998-01-01), None
patent: 0 931 788 (1999-07-01), None
patent: 1 004 578 (2000-05-01), None
patent: 6500233 (1994-01-01), None
patent: 8140528 (1996-06-01), None
patent: 8509612 (1996-10-01), None
patent: WO 90/05719 (1990-05-01), None
patent: WO 91/09967 (1991-07-01), None
patent: WO 91/10741 (1991-07-01), None
patent: WO91/10741 (1991-07-01), None
patent: WO 91/17271 (1991-11-01), None
patent: WO 92/01047 (1992-01-01), None
patent: WO 92/02190 (1992-02-01), None
patent: WO 92/03918 (1992-03-01), None
patent: WO 92/09690 (1992-06-01), None
patent: WO 92/15679 (1992-09-01), None
patent: WO 92/18619 (1992-10-01), None
patent: WO 92/20791 (1992-11-01), None
patent: WO 93/01288 (1993-01-01), None
patent: WO 93/06213 (1993-04-01), None
patent: WO 94/02602 (1994-02-01), None
patent: WO 94/25585 (1994-11-01), None
patent: WO 95/19970 (1995-07-01), None
patent: WO 95/21613 (1995-08-01), None
patent: WO 96/27583 (1996-09-01), None
patent: WO 96/33172 (1996-10-01), None
patent: WO 96/33735 (1996-10-01), None
patent: WO 96/34096 (1996-10-01), None
patent: WO 97/13760 (1997-04-01), None
patent: WO 97/22596 (1997-06-01), None
patent: WO 97/32856 (1997-09-01), None
patent: WO 98/02434 (1998-01-01), None
patent: WO 98/02437 (1998-01-01), None
patent: WO 98/02438 (1998-01-01), None
patent: WO 98/03516 (1998-01-01), None
patent: WO 98/07697 (1998-02-01), None
patent: WO 98/14451 (1998-04-01), None
patent: WO 98/16654 (1998-04-01), None
patent: WO 98/24893 (1998-06-01), None
patent: WO 98/30566 (1998-07-01), None
patent: WO 98/33768 (1998-08-01), None
patent: WO 98/34915 (1998-08-01), None
patent: WO 98/34918 (1998-08-01), None
patent: WO 98/50356 (1998-11-01), None
patent: WO 98/50433 (1998-11-01), None
patent: WO 98/54093 (1998-12-01), None
patent: WO 99/07675 (1999-02-01), None
patent: WO 99/10349 (1999-03-01), None
patent: WO 99/16755 (1999-04-01), None
patent: WO 99/24440 (1999-05-01), None
patent: WO 99/29667 (1999-06-01), None
patent: WO 99/35132 (1999-07-01), None
patent: WO 99/35146 (1999-07-01), None
patent: WO 99/45031 (1999-09-01), None
patent: WO 99/52889 (1999-10-01), None
patent: WO 99/52910 (1999-10-01), None
patent: WO 99/53049 (1999-10-01), None
patent: WO 99/61422 (1999-12-01), None
patent: WO 99/62890 (1999-12-01), None
patent: WO 00/09560 (2000-02-01), None
patent: WO 00/37504 (2000-06-01), None
patent: WO 00/50067 (2000-08-01), None
patent: WO 00/56772 (2000-09-01), None
patent: WO 2005/016970 (2005-02-01), None
Paul, Fundamental Immunology, 3rd Edition, 1993, pp. 292-295.
Rudikoff et al (Proc. Natl. Acad. Sci. USA, 79:1979-1983, Mar. 1982).
Colman (Research in Immunology, 145:33-36, 1994).
Bendig M. M. (Methods: A Companion to Methods in Enzymology, 1995; 8:83-93).
MacCallum et al (J. Mol. Biol., 262, 732-745, 1996).
Casset et al (Biochemical and Biophysical Research Communications, 307:198-205, 2003).
William E. Paul, M.D. Fundamental Immunology, 3d ed. p. 242. 1993.
Kato, Faria, Stannard, Roberts, and Le Roith. Role of tyrosine kinase activity in signal transduction by the insulin-like growth factor-I (IGF-I) receptor. Journal of Biological Chemistry, 1993. vol. 268, pp. 2655-2661.
Steele-Perkins and Roth. Monoclonal antibody aIR-3 inhibits the ability of insulin-like growth factor II to stimulate a signal from the type I receptor without inhibiting its binding. Biochemical and Biophysical Research Communications, 1990. vol. 171, pp. 1244-1251.
Soos, Field, Lammers, Ullrich, Zhang, Roth, Andersen, Kjeldsen, and Siddle. A panel of monoclonal antibodies for the type I insulin-like growth factor receptor. Journal of Biological Chemistry, 1992. vol. 267, pp. 12955-12963.
Cullen, Yee, Sly, Perdue, Hampton, Lippman, and Rosen. Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Research, 1990. vol. 50, pp. 48-53.
Altschul et al., “Basic local alignment search tool,”Journal of Molecular Biology, 215(1):403-410 (1990).
Altschul et a
Beebe Jean
Cohen Bruce D
Corvalan Jose R
Gallo Michael
Miller Penelope E
Amgen Fremont Inc.
Gunnison Jane T.
Gussow Anne M.
Helms Larry R.
Li Z. Ying
LandOfFree
Antibodies to insulin-like growth factor I receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies to insulin-like growth factor I receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to insulin-like growth factor I receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4235578